Linus Angenendt

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Blood

Blood advances

EJHaem

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Eloisa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz, Franca Carlotta Seifert, Vijay Alla, Thorben Hennig, Linus Angenendt, Wolfgang Hartmann, Sebastian Wolf, Hubert Serve, Thomas Oellerich, Georg Lenz, Carsten Muller-Tidow, Christoph Schliemann, Otmar Huber, Martin Dugas, Matthias Mann, Ashok Kumar Jayavelu, Jan-Henrik Mikesch, Maria Francisca Arteaga
Epigenetic control over cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia. Blood (2024)
Eloisa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz, Franca Carlotta Seifert, Vijay Alla, Thorben Hennig, Linus Angenendt, Wolfgang Hartmann, Sebastian Wolf, Hubert Serve, Thomas Oellerich, Georg Lenz, Carsten Muller-Tidow, Christoph Schliemann, Otmar Huber, Martin Dugas, Matthias Mann, Ashok Kumar Jayavelu, Jan-Henrik Mikesch, Maria Francisca Arteaga
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia. Blood 143 (22) (2024)
Eloisa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz, Franca Carlotta Seifert, Vijay Alla, Thorben Hennig, Linus Angenendt, Wolfgang Hartmann, Sebastian Wolf, Hubert Serve, Thomas Oellerich, Georg Lenz, Carsten Muller-Tidow, Christoph Schliemann, Otmar Huber, Martin Dugas, Matthias Mann, Ashok Kumar Jayavelu, Jan-Henrik Mikesch, Maria Francisca Arteaga
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia. Blood 143 (22) (2024)
Eloisa Felipe Fumero, Carolin Walter, Joris Maximillian Frenz, Franca Carlotta Seifert, Vijay Alla, Thorben Hennig, Linus Angenendt, Wolfgang Hartmann, Sebastian Wolf, Hubert Serve, Thomas Oellerich, Georg Lenz, Carsten Muller-Tidow, Christoph Schliemann, Otmar Huber, Martin Dugas, Matthias Mann, Ashok Kumar Jayavelu, Jan-Henrik Mikesch, Maria Francisca Arteaga
Epigenetic control over cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia. Blood (2024)
Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, Lars Haalck, Jörg Gromoll, Stefan Schlatt, Rita Exeler, Annalen Bleckmann, Georg Lenz, Sebastian Wolf, Björn Steffen, Wolfgang E Berdel, Christoph Schliemann, Benjamin Risse, Linus Angenendt
Deep Learning Predicts Therapy-Relevant Genetics in Acute Myeloid Leukemia from Pappenheim-stained Bone Marrow Smears. Blood advances (2023)
Inna Shaforostova, Simon Call, Georg Evers, Christian Reicherts, Linus Angenendt, Matthias Stelljes, Wolfgang E Berdel, Alexander Pohlmann, Jan-Henrik Mikesch, Frank Rosenbauer, Georg Lenz, Christoph Schliemann, Klaus Wethmar
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis. EJHaem 5 (1) (2023)
Inna Shaforostova, Simon Call, Georg Evers, Christian Reicherts, Linus Angenendt, Matthias Stelljes, Wolfgang E Berdel, Alexander Pohlmann, Jan-Henrik Mikesch, Frank Rosenbauer, Georg Lenz, Christoph Schliemann, Klaus Wethmar
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis. EJHaem 5 (1) (2023)
Andrew F Berdel, Leo Ruhnke, Linus Angenendt, Martin Wermke, Christoph Röllig, Jan-Henrik Mikesch, Annika Scheller, Teresa Hemmerle, Mattia Matasci, Klaus Wethmar, Torsten Kessler, Mirjam Gerwing, Daniel Hescheler, Michael Schäfers, Wolfgang Hartmann, Bianca Altvater, Claudia Rossig, Martin Bornhäuser, Georg Lenz, Matthias Stelljes, Bjoern Rueter, Dario Neri, Wolfgang E Berdel, Christoph Schliemann
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse. Blood advances 6 (12) (2022)
Linus Angenendt, Christoph Röllig, Pau Montesinos, Farhad Ravandi, Gunnar Juliusson, Christian Recher, Raphaël A Itzykson, Zdenek Racil, Andrew H Wei, Christoph Schliemann
Revisiting Co-existing Chromosomal Abnormalities in NPM1-mutated AML in Light of the Revised ELN 2022 classification. Blood (2022)
Christoph Schliemann, Torsten Kessler, Andrew F Berdel, Teresa Hemmerle, Linus Angenendt, Bianca Altvater, Claudia Rossig, Jan-Henrik Mikesch, Georg Lenz, Michael Schäfers, Dario Neri, Matthias Stelljes, Wolfgang E Berdel
Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation. British journal of haematology 192 (6) (2021)
Linus Angenendt, Marius Wöste, Jan-Henrik Mikesch, Maria Francisca Arteaga, Adrian Angenendt, Sarah Sandmann, Wolfgang E Berdel, Georg Lenz, Martin Dugas, Soheil Meshinchi, Christoph Schliemann, Claudia Rossig
Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML. Blood advances 5 (21) (2021)
Tim Sauer, Kathan Parikh, Sandhya Sharma, Bilal Omer, David Sedloev, Qian Chen, Linus Angenendt, Christoph Schliemann, Michael Schmitt, Carsten Müller-Tidow, Stephen Gottschalk, Cliona M Rooney
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood 138 (4) (2021)
Clément Larrue, Nathan Guiraud, Pierre-Luc Mouchel, Marine Dubois, Thomas Farge, Mathilde Gotanègre, Claudie Bosc, Estelle Saland, Marie-Laure Nicolau-Travers, Marie Sabatier, Nizar Serhan, Ambrine Sahal, Emeline Boet, Sarah Mouche, Quentin Heydt, Nesrine Aroua, Lucille Stuani, Tony Kaoma, Linus Angenendt, Jan-Henrik Mikesch, Christoph Schliemann, François Vergez, Jérôme Tamburini, Christian Recher, Jean-Emmanuel Sarry
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Nature communications 12 (1) (2021)
Linus Angenendt, Isabel Hilgefort, Jan-Henrik Mikesch, Bernhard Schlüter, Wolfgang E Berdel, Georg Lenz, Matthias Stelljes, Christoph Schliemann
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Annals of hematology 100 (7) (2020)
Matthias Floeth, Sandra Elges, Joachim Gerss, Christian Schwöppe, Torsten Kessler, Tobias Herold, Eva Wardelmann, Wolfgang E Berdel, Georg Lenz, Jan-Henrik Mikesch, Wolfgang Hartmann, Christoph Schliemann, Linus Angenendt
Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia. British journal of haematology 192 (3) (2020)
Christoph Schliemann, Mirjam Gerwing, Hauke Sebastian Heinzow, Saliha Harrach, Christian Schwöppe, Moritz Wildgruber, Anna A Hansmeier, Linus Angenendt, Andrew F Berdel, Ursula Stalmann, Björna Berning, Karsten Kratz-Albers, Kristina Middelberg-Bisping, Stefanie Wiebe, Jörn C Albring, Christian Wilms, Wolfgang Hartmann, Eva Wardelmann, Tobias Krähling, Walter Heindel, Joachim Gerß, Eike Bormann, Hartmut Schmidt, Georg Lenz, Torsten Kessler, Rolf M Mesters, Wolfgang E Berdel
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study. Cancers 12 (6) (2020)
Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M Knecht, Olga Buzovetsky, Lars Kaderali, Christoph Schliemann, Hanibal Bohnenberger, Linus Angenendt, Wolfgang Hartmann, Eva Wardelmann, Tamara Rothenburger, Sebastian Mohr, Sebastian Scheich, Federico Comoglio, Anne Wilke, Philipp Ströbel, Hubert Serve, Martin Michaelis, Nerea Ferreirós, Gerd Geisslinger, Yong Xiong, Oliver T Keppler, Jindrich Cinatl
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature communications 10 (1) (2019)
Leoni Rolfes, Steffen Pfeuffer, Tobias Ruck, Susanne Windhagen, Ilske Oschlies, Hermann-Joseph Pavenstädt, Linus Angenendt, Heinz Wiendl, Julia Krämer, Sven G Meuth
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS. Neurology(R) neuroimmunology & neuroinflammation 7 (1) (2019)
Linus Angenendt, Eike Bormann, Caroline Pabst, Vijay Alla, Dennis Görlich, Leonie Braun, Kim Dohlich, Christian Schwöppe, Stefan K Bohlander, Maria Francisca Arteaga, Klaus Wethmar, Wolfgang Hartmann, Adrian Angenendt, Torsten Kessler, Rolf M Mesters, Matthias Stelljes, Maja Rothenberg-Thurley, Karsten Spiekermann, Josée Hébert, Guy Sauvageau, Peter J M Valk, Bob Löwenberg, Hubert Serve, Carsten Muller-Tidow, Georg Lenz, Bernhard J Wörmann, M Christina Sauerland, Wolfgang Hiddemann, Wolfgang E Berdel, Utz Krug, Klaus H Metzeler, Jan-Henrik Mikesch, Tobias Herold, Christoph Schliemann
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia. Leukemia 33 (12) (2019)
Linus Angenendt, Jan-Henrik Mikesch, Dennis Görlich, Alina Busch, Irina Arnhold, Claudia Rudack, Wolfgang Hartmann, Eva Wardelmann, Wolfgang E Berdel, Markus Stenner, Christoph Schliemann, Inga Grünewald
Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer. Cellular oncology (Dordrecht) 41 (5) (2018)

Linus Angenendt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Linus Angenendt